Frontiers in Nutrition (Sep 2023)

A randomized trial involving a multifunctional diet reveals systematic lipid remodeling and improvements in cardiometabolic risk factors in middle aged to aged adults

  • Claudia Balderas Arroyo,
  • Maider Greño Ocariz,
  • Oksana Rogova,
  • Mahmoud Al-Majdoub,
  • Inger Björck,
  • Juscelino Tovar,
  • Peter Spégel

DOI
https://doi.org/10.3389/fnut.2023.1236153
Journal volume & issue
Vol. 10

Abstract

Read online

BackgroundA multifunctional diet (MFD) combining foods and ingredients with proven functional properties, such as fatty fish and fiber-rich foods, among others, was developed and shown to markedly reduce cardiometabolic risk-associated factors.ObjectiveHere, we aim at examining metabolic physiological changes associated with these improvements.MethodsAdult overweight individuals without other risk factors were enrolled in an 8-week randomized controlled intervention following a parallel design, with one group (n = 23) following MFD and one group (n = 24) adhering to a control diet (CD) that followed the caloric formula (E%) advised by the Nordic Nutritional Recommendations. Plasma metabolites and lipids were profiled by gas chromatography and ultrahigh performance liquid chromatography/mass spectrometry.ResultsWeight loss was similar between groups. The MFD and CD resulted in altered levels of 137 and 78 metabolites, respectively. Out of these, 83 were uniquely altered by the MFD and only 24 by the CD. The MFD-elicited alterations in lipid levels depended on carbon number and degree of unsaturation.ConclusionAn MFD elicits weight loss-independent systematic lipid remodeling, promoting increased circulating levels of long and highly unsaturated lipids.Clinical trial registrationhttps://clinicaltrials.gov/ct2/show/NCT02148653?term=NCT02148653&draw=2&rank=1, NCT02148653.

Keywords